Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
JAMA Netw Open ; 4(1): e2030832, 2021 01 04.
Artigo em Inglês | MEDLINE | ID: mdl-33427883

RESUMO

Importance: The proportion of women and underrepresented racial and ethnic groups (UREGs) matriculating into general cardiology fellowships remains low. Objective: To assess a systematic recruitment initiative aimed at ensuring adequate matriculation of women and UREGs in a general cardiology fellowship. Design, Setting, and Participants: This quality improvement study took place at a large, tertiary academic medical center and associated Accreditation Council for Graduate Medical Education Cardiovascular Disease fellowship. Participants included cardiology fellowship and divisional leadership and general cardiology fellow applicants to the Duke Cardiovascular Disease Fellowship Program from 2017 to 2019. Data analysis was performed from December 2019 to May 2020. Exposure: Multipronged initiative that created an environment committed to ensuring equity of opportunity. This included the creation of a fellowship diversity and inclusivity task force that drafted recommendations, which included reorganization of the fellowship recruitment committee, and changes to the applicant screening process, the interview day, applicant ranking process, and postmatch interventions. Main Outcomes and Measures: The percentage of matriculating and overall women and UREGs before and after the interventions were recorded. Results: The fellowship received a mean (SD) of 462 (55) applications annually before the interventions (2006-2016) and 611 (27) applications annually after the interventions (2017-2019). Between the 10-year period before the interventions and the 3-year period during the interventions, there was a significant increase in the annual mean (SD) percentage of women (22.4% [2.9%] vs 26.4% [0.07%]; P < .001) and UREG applicants (10.5% [1.1%] vs 12.5% [1.9%]; P = .01) to the program. Among applicants interviewed, the percentage of women increased from 20.0% to 33.5% (P = .01) and that of and UREGs increased from 14.0% to 20.0% (P = .01). Before the interventions, a mean (SD) of 23.2% (16.2%) women and 9.7% (7.8%) UREGs matriculated as first-year fellows, whereas after the interventions, a mean (SD) of 54.2% (7.2%) women and 33.3% (19.0%) UREGs matriculated as first-year fellows. The proportion of the entire fellowship who were women increased from a 5-year mean (SD) of 27.0% (8.8%) to 54.2% (7.2%) after 3 years of interventions, and that of UREGs increased from 5.6% (4.6%) to 33.3% (19.0%). Overall, the proportion of applicants in the entire population who were either women or from UREGs increased from 27.8% to 66.7%. Conclusions and Relevance: After implementing interventions to promote equity of opportunity in the cardiovascular disease fellowship, the percentage of women and UREGs significantly increased in the fellowship over a 3-year time period. These interventions may be applicable to other cardiovascular disease fellowships seeking to diversify training programs.


Assuntos
Cardiologia , Etnicidade/estatística & dados numéricos , Bolsas de Estudo , Grupos Raciais/estatística & dados numéricos , Cardiologia/educação , Cardiologia/organização & administração , Diversidade Cultural , Bolsas de Estudo/organização & administração , Bolsas de Estudo/estatística & dados numéricos , Feminino , Humanos , Masculino , Grupos Minoritários/estatística & dados numéricos , North Carolina , Universidades , Mulheres
2.
J Am Heart Assoc ; 9(17): e017196, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32838627

RESUMO

Background The lack of diversity in the cardiovascular physician workforce is thought to be an important driver of racial and sex disparities in cardiac care. Cardiology fellowship program directors play a critical role in shaping the cardiology workforce. Methods and Results To assess program directors' perceptions about diversity and barriers to enhancing diversity, the authors conducted a survey of 513 fellowship program directors or associate directors from 193 unique adult cardiology fellowship training programs. The response rate was 21% of all individuals (110/513) representing 57% of US general adult cardiology training programs (110/193). While 69% of respondents endorsed the belief that diversity is a driver of excellence in health care, only 26% could quote 1 to 2 references to support this statement. Sixty-three percent of respondents agreed that "our program is diverse already so diversity does not need to be increased." Only 6% of respondents listed diversity as a top 3 priority when creating the cardiovascular fellowship rank list. Conclusions These findings suggest that while program directors generally believe that diversity enhances quality, they are less familiar with the literature that supports that contention and they may not share a unified definition of "diversity." This may result in diversity enhancement having a low priority. The authors propose several strategies to engage fellowship training program directors in efforts to diversify cardiology fellowship training programs.


Assuntos
Cardiologia/educação , Educação/ética , Bolsas de Estudo/métodos , Médicos/psicologia , Cardiologia/estatística & dados numéricos , Competência Clínica/estatística & dados numéricos , Diversidade Cultural , Educação/estatística & dados numéricos , Educação de Pós-Graduação em Medicina/métodos , Feminino , Mão de Obra em Saúde , Disparidades em Assistência à Saúde/etnologia , Disparidades em Assistência à Saúde/estatística & dados numéricos , Humanos , Masculino , Percepção , Preconceito , Inquéritos e Questionários
3.
J Am Soc Echocardiogr ; 29(12): 1144-1154.e7, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27720558

RESUMO

BACKGROUND: There is no broadly accepted standard method for assessing the quality of echocardiographic measurements in clinical research reports, despite the recognized importance of this information in assessing the quality of study results. METHODS: Twenty unique clinical studies were identified reporting echocardiographic data quality for determinations of left ventricular (LV) volumes (n = 13), ejection fraction (n = 12), mass (n = 9), outflow tract diameter (n = 3), and mitral Doppler peak early velocity (n = 4). To better understand the range of possible estimates of data quality and to compare their utility, reported reproducibility measures were tabulated, and de novo estimates were then calculated for missing measures, including intraclass correlation coefficient (ICC), 95% limits of agreement, coefficient of variation (CV), coverage probability, and total deviation index, for each variable for each study. RESULTS: The studies varied in approaches to reproducibility testing, sample size, and metrics assessed and values reported. Reported metrics included mean difference and its SD (n = 7 studies), ICC (n = 5), CV (n = 4), and Bland-Altman limits of agreement (n = 4). Once de novo estimates of all missing indices were determined, reasonable reproducibility targets for each were identified as those achieved by the majority of studies. These included, for LV end-diastolic volume, ICC > 0.95, CV < 7%, and coverage probability > 0.93 within 30 mL; for LV ejection fraction, ICC > 0.85, CV < 8%, and coverage probability > 0.85 within 10%; and for LV mass, ICC > 0.85, CV < 10%, and coverage probability > 0.60 within 20 g. CONCLUSIONS: Assessment of data quality in echocardiographic clinical research is infrequent, and methods vary substantially. A first step to standardizing echocardiographic quality reporting is to standardize assessments and reporting metrics. Potential benefits include clearer communication of data quality and the identification of achievable targets to benchmark quality improvement initiatives.


Assuntos
Pesquisa Biomédica/tendências , Confiabilidade dos Dados , Ecocardiografia/métodos , Ecocardiografia/normas , Aumento da Imagem/normas , Guias de Prática Clínica como Assunto , Garantia da Qualidade dos Cuidados de Saúde/métodos , Medicina Baseada em Evidências , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
4.
PLoS One ; 7(7): e40491, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22815751

RESUMO

BACKGROUND: Detecting and quantifying the severity of mitral regurgitation is essential for risk stratification and clinical decision-making regarding timing of surgery. Our objective was to assess specific visual parameters by cine-magnetic resonance imaging (MRI) in the determination of the severity of mitral regurgitation and to compare it to previously validated imaging modalities: echocardiography and cardiac ventriculography. METHODS: The study population consisted of 68 patients who underwent a cardiac MRI followed by an echocardiogram within a median time of 2.0 days and 49 of these patients who had a cardiac catheterization, median time of 2.0 days. The inter-rater agreement statistic (Kappa) was used to evaluate the agreement. RESULTS: There was moderate agreement between cine MRI and Doppler echocardiography in assessing mitral regurgitation severity, with a kappa value of 0.47, confidence interval (CI) 0.29-0.65. There was also fair agreement between cine MRI and cardiac catheterization with a kappa value of 0.36, CI of 0.17-0.55. CONCLUSION: Cine MRI offers a reasonable alternative to both Doppler echocardiography and, to a lesser extent, cardiac catheterization for visually assessing the severity of mitral regurgitation with specific visual parameters during routine clinical cardiac MRI.


Assuntos
Cateterismo Cardíaco , Ecocardiografia Doppler , Imageamento por Ressonância Magnética , Insuficiência da Valva Mitral/diagnóstico , Insuficiência da Valva Mitral/fisiopatologia , Feminino , Átrios do Coração/diagnóstico por imagem , Átrios do Coração/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência da Valva Mitral/diagnóstico por imagem , Tamanho do Órgão , Estudos Retrospectivos , Volume Sistólico , Disfunção Ventricular Esquerda/diagnóstico por imagem
5.
Cardiol Clin ; 25(1): 1-13, v, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17478237

RESUMO

Cardiovascular magnetic resonance (CMR) is now considered the "gold standard" for the assessment of regional and global systolic function, myocardial infarction and viability, and congenital heart disease. At specialized centers, CMR has become a clinical workhorse for the evaluation of ischemic heart disease and for heart failure and cardiomyopathies. Despite this versatility, general acceptance of CMR in cardiovascular medicine has progressed slowly. This article provides a basic understanding of important operational considerations when starting a CMR service and describes a conceptual framework of the components of a CMR examination.


Assuntos
Doenças Cardiovasculares/diagnóstico , Imagem Cinética por Ressonância Magnética/métodos , Doenças Cardiovasculares/patologia , Educação Médica Continuada , Desenho de Equipamento , Planos de Pagamento por Serviço Prestado , Humanos , Processamento de Imagem Assistida por Computador , Imagem Cinética por Ressonância Magnética/economia , Admissão e Escalonamento de Pessoal , Sistemas de Informação em Radiologia , Interface Usuário-Computador
6.
J Am Soc Echocardiogr ; 18(12): 1381-4, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16376770

RESUMO

OBJECTIVES: Our study was designed to demonstrate that transesophageal echocardiography using a 3.3-mm monoplane probe can accurately evaluate the left atrium for patients with arrhythmias before cardioversion. BACKGROUND: Standard probes cause discomfort during intubation requiring sedation, but miniature probes do not. METHODS: With topical anesthesia alone, a 3.3-mm probe was used for transesophageal echocardiography in 60 patients. After intravenous sedation, standard transesophageal echocardiography was then performed. RESULTS: In 51 of 60 patients, the left atrium was visualized with the 3.3-mm probe. In 43 of 51 patients the appendage was clear. A thrombus was seen in 7 patients on both studies. In one patient spontaneous echocontrast was seen only with the 3.3-mm probe (sensitivity 100%, specificity 97%). In 9 of 60 patients, the appendage could not be assessed. CONCLUSIONS: In many patients the 3.3-mm probe can visualize the appendage and obviate the need for sedation. Technical advances will improve image quality with miniature probes.


Assuntos
Fibrilação Atrial/diagnóstico por imagem , Ecocardiografia Transesofagiana/instrumentação , Átrios do Coração/diagnóstico por imagem , Cardiopatias/diagnóstico por imagem , Trombose/diagnóstico por imagem , Fibrilação Atrial/complicações , Ecocardiografia Transesofagiana/métodos , Desenho de Equipamento , Análise de Falha de Equipamento , Feminino , Humanos , Masculino , Miniaturização , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Método Simples-Cego , Trombose/complicações , Transdutores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA